DrugPatentWatch Database Preview
Drugs in Development Information for Volasertib
» See Plans and Pricing
What is the drug development status for Volasertib?
Volasertib is an investigational drug.
There have been 25 clinical trials for Volasertib.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2013.
The most common disease conditions in clinical trials are Leukemia, Leukemia, Myeloid, Acute, and Leukemia, Myeloid. The leading clinical trial sponsors are Boehringer Ingelheim, National Comprehensive Cancer Network, and Yale University.
There are seventeen US patents protecting this investigational drug and one hundred and seventy-six international patents.
Summary for Volasertib
| US Patents | 17 |
| International Patents | 176 |
| US Patent Applications | 47 |
| WIPO Patent Applications | 308 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2013-01-01) |
| Vendors | 49 |
Recent Clinical Trials for Volasertib
| Title | Sponsor | Phase |
|---|---|---|
| A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia | University of Alberta | Phase 1 |
| A Study to Find a Safe Dose of Volasertib Given in Addition to Standard Salvage Chemotherapy in Children (Age 3 Months to Less Than 18 Years) With Acute Myeloid Leukaemia, in Whom Front-line Chemotherapy Failed | Boehringer Ingelheim | Phase 1 |
| Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL | Boehringer Ingelheim | Phase 1 |
Clinical Trial Summary for Volasertib
Top disease conditions for Volasertib
Top clinical trial sponsors for Volasertib
US Patents for Volasertib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Volasertib | Start Trial | Specific salt, anhydrous and crystalline form of a dihydropteridione derivative | Boehringer Ingelheim International GmbH (Ingelheim, DE) | Start Trial |
| Volasertib | Start Trial | Process for the manufacture of dihydropteridinones | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) | Start Trial |
| Volasertib | Start Trial | Intermediate compounds useful for the manufacture of dihydropteridinones | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) | Start Trial |
| Volasertib | Start Trial | Process for the manufacture of dihydropteridinones | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) | Start Trial |
| Volasertib | Start Trial | Specific salt, anhydrous and crystalline form of a dihydropteridione derivative | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) | Start Trial |
| Volasertib | Start Trial | Crystalline form of the free base N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7r)-7-et- hyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino- ]-3-methoxy-benzamide | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) | Start Trial |
| Volasertib | Start Trial | Substituted pyrazinone derivatives for use in MCH-1 mediated diseases | Janssen Pharmaceutica, N.V. (Beerse, BE) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Volasertib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Volasertib | Argentina | AR059349 | 2026-02-08 | Start Trial |
| Volasertib | Australia | AU2007213752 | 2026-02-08 | Start Trial |
| Volasertib | Brazil | BRPI0707604 | 2026-02-08 | Start Trial |
| Volasertib | Canada | CA2635834 | 2026-02-08 | Start Trial |
| Volasertib | China | CN101379064 | 2026-02-08 | Start Trial |
| Volasertib | China | CN102093360 | 2026-02-08 | Start Trial |
| Volasertib | Eurasian Patent Organization | EA015389 | 2026-02-08 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
